Temsirolimus (CCI-779, NSC 683864) (C007B-281477)

Temsirolimus (CCI-779) directly inhibits mTOR kinase activity with IC50 values of 1.76 ± 0.15 μM.A potent inhibitor of FRAP (mTOR) kinase activityapplication：Temsirolimus is used as a rapamycin derivative with anti-cancer activity that inhibits mTOR. Temsirolimus is an antiproliferative and antiangiogenic, the first-in-class mTOR inhibitor approved for the treatment of patients with advanced poor prognosis renal cell carcinoma. Specification: ≥98% Molecular Formula: C56H87NO16 Molecular Weight: 1030.29 PubChem CID: 6918289 Isomeric SMILES: C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OC(=O)C(C)(CO)CO)C)/C)O)OC)C)C)/C)OC Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/T126606-SCI_c4f01ed1e23ad0da3084e02665b8a07c.pdf

UPC:

51434703

Condition:

New

Weight:

1.06 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

T126606-5mg

CAS:

162635-04-3

Product Size:

5mg

Hazard Statement Codes:

H360

Precautionary Statement Codes:

P273:P280:P391:P405:P501